Single-Dose Local Radiation Therapy Compared With Ibandronate in Treating Patients With Localized Metastatic Bone Pain
Status:
Completed
Trial end date:
2011-07-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Ibandronate may be effective in reducing bone pain caused by metastatic cancer.
Radiation therapy uses high-energy x-rays to damage tumor cells. It is not yet known whether
ibandronate is more effective than standard treatment with radiation therapy in treating
metastatic bone pain.
PURPOSE: This phase III randomized clinical trial is studying ibandronate to see how well it
works compared to single-dose local radiation therapy in treating patients with localized
metastatic bone pain.